Related Experiment Video

Updated: Jun 17, 2026

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans
08:12

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Published on: October 5, 2020

Lin28-let7 modulates radiosensitivity of human cancer cells with activation of K-Ras

Jee-Sun Oh1, Jae-Jin Kim, Ju-Yeon Byun

  • 1Medical Science Research Institute, Seoul National University Bundang Hospital, Seongnamsi, Korea.

International Journal of Radiation Oncology, Biology, Physics
|December 17, 2009
PubMed
Abstract

Insights

Targeting the Lin28-let7 microRNA network can overcome radioresistance in cancers with activated K-Ras signaling. This approach radiosensitized cancer cells with K-RAS mutations but not normal cells.

Area of Science:

  • Molecular Biology
  • Cancer Therapeutics
  • MicroRNA Regulation

Background:

  • Cancer radioresistance is a significant clinical challenge.
  • The Lin28-let7 microRNA pathway regulates gene expression and is implicated in cancer.
  • K-Ras signaling is frequently activated in various cancers and associated with radioresistance.

Purpose of the Study:

  • To investigate the therapeutic potential of modulating the Lin28-let7 microRNA regulatory network.
  • To determine if targeting this network can overcome radioresistance in cancer cells with activated K-Ras signaling.

Main Methods:

  • Utilized A549 lung and ASPC1 pancreatic cancer cell lines with K-RAS mutations.
  • Employed transfection with pre-let-7a microRNA or Lin28 siRNA.
  • Performed clonogenic assays, qRT-PCR, and Western blot analysis to assess radiosensitivity and molecular changes.

Main Results:

  • Overexpression of let-7a reduced K-Ras expression and sensitized A549 cells to radiation.
  • Inhibition of Lin28 (a let-7 repressor) decreased K-Ras expression and radiosensitized both A549 and ASPC1 cells.
  • No radiosensitization was observed in SQ20B cells with wild-type K-RAS or normal human fibroblasts (HDF).

Conclusions:

  • The Lin28-let7 regulatory network represents a promising therapeutic target.
  • Modulating this network can potentially overcome radioresistance specifically in human cancers with activated K-Ras signaling.

More Related Videos

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

The Soft Agar Colony Formation Assay08:01

The Soft Agar Colony Formation Assay

Published on: October 27, 2014

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...